Hepatitis C virus infection
Identification of apolipoprotein C-III as a potential plasmatic biomarker associated with the resolution of hepatitis C virus infection
11
Hepatitis C virus infection: Are there still specific problems with genotype 3?
15
Neutralizing antibodies in hepatitis C virus infection.
26
Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France
21
Chronic hepatitis C virus infection, a new cardiovascular risk factor?
20
Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma
14
Hepatitis C Virus Infection, a New Modifiable Cardiovascular Risk Factor
16
Hepatitis C virus infection and chronic kidney disease: Time for reappraisal
31
Opening the door for hepatitis C virus infection in genetically humanized mice.
13
Hepatitis C Virus Infection and Rheumatic Diseases: The Impact of Direct-Acting Antiviral Agents
18
View of New treatments for chronic hepatitis C virus infection
10
Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes.
19
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination.
2
Rheumatologic Manifestations of Hepatitis C Virus Infection
16
Hepatitis C virus infection and hospital-related outcomes: a systematic review protocol
5
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody
20
Evidence that hepatitis C virus genome partly controls infection outcome
16
Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infection
32
Prospective study of Hepatitis E Virus infection among pregnant women in France.
4
Coinfection of hepatitis B and hepatitis Delta virus in Belgiumy: a multicenter BASL Study. Prospective epidemiolog and comparison with HBV mono-infection
5